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ABSTRACT
Vasopressin V2 receptors, expressed from an x-chromosomal gene, 
are involved in antidiuresis, but also in release of coagulation factor 
VIII and von Willebrand factor (vWF). The present study describes 
autosomal recessive nephrogenic diabetes insipidus (NDI) in a large 
cluster of patients in Israe li Lower-Galilee. Evidence for an intact V2 
receptor was concluded by their normal increase in factor VIII and 
vWF after desmopressin infusion. Thus, in these patients a defect in 
the pathway beyond the V2 receptor was suspected. The recent cloning 
of the human Aquaporin-2 gene enabled us to test this gene as a 
candidate for such a postreceptor defect. Direct sequencing of the
V ASOPRESSIN exerts its effects through stimulation of at 
least two types of receptors: Vu receptors mediate the 
pressor response of this hormone and other actions, such as 
glycogenolysis and platelet aggregation. V2 receptors are 
involved in antidiuresis, but also in release of coagulation 
factor VIII, von Willebrand factor (vWF), and tissue-type 
plasminogen activator (t-PA) (1). Mutations in the x-chro- 
mosomal V2 receptor result in X-linked nephrogenic diabetes 
insipidus (NDI) (2, 3). Biochemically, the V2 receptor defect 
of X-linked NDI is reflected by a blunted antidiuretic re­
sponse to the V2 receptor agonist desmopressin. Moreover, 
patients with X-linked NDI do not show  an increase of co­
agulation and fibrinolytic factors to desm opressin adminis­
tration (4). The X-linked type of NDI is the most frequent 
form of the disease, but some families have been described 
in which NDI shows an autosomal recessive m ode of inher­
itance. In previous studies, w e have found evidence for an 
intact V2 receptor in four NDI patients, as concluded by their 
normal increase in factor VIII and vWF after desmopressin  
infusion (5,6). Thus, in these patients a defect in the pathway 
beyond the V2 receptor was suspected.
By screening kidney cDNA and cosmid libraries with a rat 
Aquaporin-2 cDNA as a probe, the human Aquaporin-2 
(AQP2) gene was identified, assigned to chromosome 12, and 
found to be mutated in a patient w ith autosomal recessive 
NDI (7). Subsequently, three additional NDI families with  
mutations in the AQP2 gene have been reported (8).
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Aquaporin-2 gene revealed a G298T substitution causing a 
GlylOOStop nonsense mutation in the third transmembrane region. 
Because this putative disease-causing mutation was identified in 
index patients of different families, we suggest tha t all patients are 
descendants of a common ancestor. Thus, this new entity is charac­
terized by an autosomal recessive NDI. The differential response of 
clotting factors and urine osmolality to desmopressin may provide a 
simple tool for clinical diagnosis of a V2-postreceptor defect. The early 
stop-codon of Aquaporin-2 results in complete resistance to vasopres­
sin antidiuretic effect. (J  Clin Endocrinol Metab 82: 686-689,1997)
The present study describes autosomal recessive NDI in a 
large cluster of patients in Israel's Lower-Galilee. We have 
identified a new mutation in the AQP2 gene. Because this 
pxxtative disease-causing mutation was identified in index 
patients of different families, w e suggest that all patients are 
descendants of a common ancestor.
Subjects and Methods
The pedigrees of the patients are depicted in Fig. 1 . The families are 
of Bedouin-Arab origin, w here first cousin m arriage is traditional. Al­
though  w e have no t been able to trace the relationship  of these families 
w ith  each other, such relation can b e  assum ed to exist as members of 
these three families live w ithin an area of 20 km.
Presenting w ith  neonatal fever and  vom iting  (6/11 patients) or failure 
to thrive (4/11 patients), NDI w as d iagnosed  by dem onstration of poly­
uria  of 161-250 m L /k g /d a y , low  u rin ary  osmolality, w ith  maximal 
concentration to 52-102 m O sm /k g , h igh  sim ultaneous plasm a osmola­
lity of 296-326 m O sm /kg , and  serum  sod ium  concentration of 147-168 
m E q /L  and  lack of response to vasopressin. The clinical picture was also 
characterized by fetal distress (3 /5  patients), short sta ture  with a mean 
height of -1.05 su, slow psychom otor developm ent and mental retar­
dation  (6 / 1 1  patients), and psychosis in  one patient, w ho presented with 
extreme and aggressive anger at night, w hich m ight have been related 
to thirst.
Two pairs of the obligatory heterozygous paren ts of affected patients 
w ere screened for a possible concentration defect. Their fasting serum 
sodium  (139-142 m E q/L ) urine osm olality (780-940 m O sm /kg) was 
norm al, as were the 24-h urine volum es (21-29 m L /k g /d ) .
Desmopressin infusion test
D esm opressin infusion tests were perform ed in  7 of the patients and
5 healthy controls. Before desm opressin  infusion a water-load of 600 
m L /m 2 w as given orally to suppress endogenous vasopressin. Basal 
urine was collected for an hour. Starting at zero time, desmopressin 
(Minirin, Ferring, M almo, Sweden) w as infused over 10 m in in a dose 
of 0.3 /Lig/kg. U rine and  blood w ere collected a t 0, 60, and 120 min. 
Plasm a and  urine osmolality w ere m easured  w ith a cryosmometer.
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P i g . 1. Pedigrees of the three families 
w ith  NDI and Aquaporin-2 mutations. 
P atien ts designated in the text are iden­
tified by the family initial-generation- 
patien ts number in the respective gen­
eration (i.e. K-VI-2).
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Coagulation factors
Factor VIII activity was measured by a single-stage assay, as previ­
ously reported (9). The normal range in 30 healthy controls was 50-150 
U/dL. vWF antigen was measured by an enzyme-immunoassay (10), 
with reagents purchased from Stago (Asnieres, France).
Mutation analysis
Chromosomal DNA was isolated from blood using the salt ex­
traction method (11). Amplification of 100 ng of genomic DNA was 
performed in 100 /xL, using primers flanking exon 1 of the AQP2 gene. 
After purification of the polymerase chain reaction (PCR) product, the 
same primers were used to sequence both strands in the cycle se­
quencing reaction with the fluorescence-based Applied Biosystems 
model 373A DNA-sequencing system (7). Restriction mapping of the 
crude exon I PCR product was carried out with Ms pi, and the di­
gestion products were resolved on 2% agarose and visualized with 
ethidiumbromide.
Results
In Fig. 2, the results of the desmopressin infusion test in 
seven patients and five controls are presented. Basal plasma
osmolality was 288 ±  2 m O sm /kg in controls and 293 ± 7 
m O sm /kg in NDI patients (P <  0.05). Urinary osmolality 
increased from 285 ± 112 to 640 ±  92 m O sm /kg in controls, 
but remained dilute at 81 ± 9 m O sm /kg in NDI patients. 
Clotting factor VIII increased in control from 75 ± 5 to 204 ± 
73 U /d l and in NDI patients from 132 ± 2 3  (P <  0.01) to 293 ± 
175 U /d l (NS). vWF-antigen increased in control from 86 ±
15 to 180 ±  28 U /d L  and in NDI patients from 178 ± 42 (P <
0.02) to 302 ±  130 U /d L  (P <  0.05).
Direct DNA sequencing of the AQP2 gene of the index 
patients VI-1 of the H family and VI-4 of the G family re­
vealed a G298T substitution causing a GlylOOStop nonsense 
mutation in the third transmembrane region. As this muta­
tion destroys the Mspl site present in the first exon, a simple 
restriction site PCR test for carriership was possible. In both 
patients the 474 bp PCR fragment for exon I could not be cut 
with Mspl, confirming the homozygous nature of the mu­
tation found, In the parents of both patients the 474 bp 
fragment and a 370 bp fragment were visible on EtBr-stained
Fig. 2. Desmopressin infusion test in 7 
NDI patients (•)  and 5 control (O). A 
tap-water load of 600 mL/m2 was given 
orally, and basal urine was collected for 
an hour. Starting at time 0, desmopres­
sin (MinirinR, Ferring, Malmo, Sweden) 
was infused over 10 min in a dose of 0.3 
Hg/kg. Urine and blood were collected at 
0, 1, and 2  h . Mean ± s d .
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